One of only 25 U.S. centers eligible to offer this complex surgery, our heart transplantation team is internationally renowned for spearheading innovative methods.
The results of a Montefiore Einstein research team’s study showed more than 80% of clinical trial participants were completely free of atrial fibrillation recurrence 12 months after the procedure.